bimagrumab semaglutide combination trial New drugs for the treatment of obesity: do we need approaches to preserve muscle mass? | Reviews in Endocrine and Metabolic Disorders

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial

29.37

★★★★☆4.8 (126)

Combined use of semaglutide with an investigational monoclonal antibody called bimagrumab produced significant fat mass loss while preserving lean mass, results from the phase 2b BELIEVE study found. http://ms.spr.ly/6180SLSUq

26.74

★★★★★4.9 (98)

Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism

23.82

★★★★★5.0 (157)

New phase 2 data just published in Nature Medicine on bimagrumab combined with semaglutide. Swipe for the breakdown. Follow @adam_nessim for more. Source: Heymsfield et al., Nature Medicine, March 2, 2026

29.77

★★★★★4.7 (84)

🛑Lilly halts phase 2 trial of bimagrumab + semaglutide in type 2 #diabetes. Was the decision based on strategy or safety? Looking back, bimagrumab monotherapy in #T2DM did NOT improve lipids and

22.89

★★★★★4.9 (203)

Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines

29.84

★★★★★5.0 (176)

Why Is Eli Lilly Betting Big With Weight Loss Drug Bimagrumab?

27.65

★★★★★4.8 (132)